Fulgent Genetics (FLGT) Invested Capital (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Invested Capital data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Invested Capital fell 6.58% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 6.58% YoY) and the FY2025 annual result came in at $1.1 billion, down 1.44% from the prior year.
• Invested Capital retreated to $1.1 billion in Q1 2026 per FLGT's latest filing, from $1.1 billion in the prior quarter.
• The five-year high for Invested Capital was $1.3 billion in Q2 2022, with the low at $1.1 billion in Q1 2026.
• Average Invested Capital over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
• Year-over-year, Invested Capital surged 62.62% in 2022 and fell 10.13% in 2024.
• Fulgent Genetics' Invested Capital stood at $1.3 billion in 2022, then retreated by 9.74% to $1.2 billion in 2023, then climbed by 0.07% to $1.2 billion in 2024, then decreased by 1.44% to $1.1 billion in 2025, then decreased by 5.73% to $1.1 billion in 2026.
• Business Quant data shows FLGT's Invested Capital at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.